Skip to content
AlternativeMed

Pygeum (Prunus africana): Uses, Evidence and Safety

Pygeum (Prunus africana) bark extract is used for prostate urinary symptoms. What a Cochrane review and EU and NIH sources say, the conservation status of the tree, and safety points.

Content last updated . This page has not been medically reviewed.

Close-up of pygeum (prunus africana): uses, evidence and safety

Safety first. Natural products can cause side effects and interact with medicines. Read herb safety and interactions before you use anything on this page.

HerbPrunus africana (Hook.fil.) Kalkman, Pygeum africanum Hook f. (older name)

What is Pygeum good for?

What the body uses it for, and how strong the evidence is. A normal job in the body is not proof that extra supplements add benefit; each card says which.

Urinary symptoms from an enlarged prostate (BPH)

Preliminary or mixed

A Cochrane review of 18 trials in 1,562 men found a standardised extract improved urinary symptoms and flow compared with placebo. The trials were small, short and used different products.

Supplements: Some benefit over placebo in short, small trials; long-term effect not known.

Comparison with standard BPH medicines

Not enough evidence

No trials compared pygeum with standard BPH drugs, so it is not known how it compares.

Supplements: No evidence on how it compares with standard treatment.

Regulatory status in the EU

Clinically supported

The EU herbal committee lists a specific bark extract as a traditional herbal medicine for relief of lower urinary tract symptoms related to BPH, after a doctor has excluded serious conditions. It is based only on long-standing use.

Supplements: Applies only to the defined extract, for adult men, under medical supervision; the EU describes it as traditional use only.

Anti-inflammatory effect

Lab or animal research only

Laboratory studies suggest pygeum compounds have anti-inflammatory effects. MSK says human data are lacking.

Supplements: No benefit shown in people.

Androgen receptor and prostate cancer cell studies

Lab or animal research only

In cells and animals, pygeum compounds block the androgen receptor and slow prostate cancer cell growth. This has not been shown to help people.

Supplements: No benefit shown in people; do not use as a cancer treatment.

Sexual performance

Not enough evidence

MSK says no scientific evidence supports use for sexual performance.

Supplements: No evidence of benefit.

Traditional use for kidney and urinary problems

Not enough evidence

Bark extracts have traditionally been used for inflammation, kidney diseases, urinary problems and prostate inflammation. Tradition is not proof of effect.

Supplements: Traditional use only; not tested for kidney disease in the sources read.

Connected topics

Open a group to see how each topic connects and how strong the evidence is.

Health goals (1)
  • Men’s VitalityPreliminary or mixed

    Used by men for urinary symptoms of an enlarged prostate. A Cochrane review found some benefit over placebo, but the trials were small and short.

Body systems (2)
  • Kidney & UrinaryPreliminary or mixed

    Used for urinary symptoms linked to an enlarged prostate. Evidence is limited: small, short trials with varied products.

  • Urinary SystemPreliminary or mixed

    Used for lower urinary tract symptoms related to BPH. Evidence is limited; see a doctor first to exclude serious causes.

Body parts (1)
  • Reproductive OrgansPreliminary or mixed

    The prostate is the target organ for the studied use (BPH urinary symptoms). Evidence is limited.

Conditions & symptoms (4)
  • Benign Prostatic HypertrophyPreliminary or mixed

    A Cochrane review found a standardised extract improved urinary symptoms versus placebo in small, short trials; the EU lists it as traditional use only.

  • Lower Urinary Tract SymptomsPreliminary or mixed

    The EU traditional use is relief of lower urinary tract symptoms related to BPH, after serious conditions are excluded by a doctor.

  • NocturiaPreliminary or mixed

    The Cochrane review reported nocturia reduced by 19% versus placebo, in small and short trials.

  • Urinary RetentionDocumented risk

    Urinary retention is a warning sign: the EU monograph says to see a doctor if it occurs during use.

Documented risks and interactions (6)
  • Mild stomach and bowel effects. Clinical studies found pygeum generally well tolerated, with mild effects such as nausea, stomach upset, diarrhoea, constipation and headache. The EU monograph lists rare digestive disorders.
  • Allergy to pygeum. The EU monograph lists hypersensitivity to the active substance as a contraindication.
  • Not for women, children or pregnancy. The EU monograph says there is no relevant use in women or in people under 18, that pregnancy and breastfeeding are not relevant, and that no fertility data are available.
  • See a doctor first; symptoms can have serious causes. Fever, spasms, blood in the urine, painful urination or urinary retention, or worsening symptoms, need a doctor. The EU monograph says use only after serious conditions are excluded.
  • Drug interactions and long-term safety. The EU monograph and assessment report report no known drug interactions, but this is an absence of reports, not proof of safety. MSK says long-term effects are not known. Animal tests at very high doses showed liver, kidney and heart damage; the EU report judged normal use safe, and the monograph notes carcinogenicity tests were not done.
  • Conservation of the tree. Prunus africana is listed in CITES Appendix II owing to overexploitation, so the source of bark matters.

Explore all 414 herbs

Key points first

  • Pygeum is an extract of tree bark used for urinary symptoms linked to an enlarged prostate. Evidence is limited: the main review found small, short trials with different products. [1]
  • Urinary symptoms can have serious causes. The EU herbal monograph says pygeum is for use after serious conditions have been excluded by a doctor, and that a doctor should be consulted if symptoms worsen or if fever, spasms, blood in the urine, painful urination or urinary retention occur. [2]
  • The tree is a threatened species. A European assessment report says that, owing to overexploitation and other factors, Prunus africana is listed in Appendix II of CITES, the convention on international trade in endangered species. [3]

Overview

Pygeum is made from the bark of an evergreen tree called the African plum tree. [4] [3] Extracts of the bark have traditionally been used for inflammation, kidney diseases, urinary problems and prostate inflammation. [4] This page covers the herb. For prostate herbs as a group, see herbs for prostate and urinary symptoms, and for symptoms themselves see urinary symptoms and enlarged prostate.

Names, plant part and conservation

The accepted scientific name is Prunus africana (Hook.fil.) Kalkman, in the rose family (Rosaceae). [5] An older name, Pygeum africanum Hook f., is still used on products and in older studies. [3] The part used is the dried bark of the trunk, stems and branches. [3] Common names include pygeum and African plum tree or African prune. [3]

On conservation, the EMA report quoted above notes the CITES Appendix II listing. [3] Whether a given product is sustainably harvested is not described in the sources we read. See at-risk medicinal plants and conservation and African herbal medicine overview.

Traditional use (not proof of effect)

NCCIH says bark extracts have traditionally been used for inflammation, kidney diseases, urinary problems and prostate gland inflammation. [4] A cancer center review lists traditional use for lower urinary tract symptoms with BPH (benign prostatic hyperplasia, a non-cancerous enlarged prostate). [6] The EU monograph describes the product as a traditional herbal medicine based exclusively on long-standing use. [2] These sources do not name the peoples whose knowledge underlies this use.

What research shows

UseWhat the source foundStrength of evidencePopulation and form studied
BPH urinary symptomsA Cochrane review of 18 randomized trials (1,562 men) found a moderately large improvement in combined symptoms and flow measures versus placebo, and men were more than twice as likely to report overall improvement. [1]Promising but limitedMen with BPH; standardized extracts; mean study length 64 days [1]
Quality of those trialsThe review said the studies were small, short, used varied doses and preparations, and rarely used validated symptom scales. It found no trials comparing pygeum with standard drugs. [1] NCCIH repeats this and says the evidence is limited. [4]Limits of the evidenceSame review [1]
Compared with standard BPH medicinesProper evidence not found. The Cochrane review (searched through 2000) found no such trials, and a cancer center review says larger studies are needed to show usefulness compared with standard treatments. [1] [6]No good evidence foundNone
Laboratory effects (germs, androgen receptor, prostate cancer cells)Cell and animal studies indicate antibacterial and antifungal activity, blocking of the androgen receptor, and effects against prostate cancer cells. [6]Preclinical (cells or animals); not evidence for peopleCells and animals [6]

Forms and why the form matters

The EU monograph covers a soft extract made with a specific solvent, in solid forms taken by mouth, and does not cover raw bark or teas. [2] The EU monograph gives a traditional single dose of 50 mg and a daily dose of 100 mg of extract for adult men. [2] That is the official monograph amount for that extract (EMA, European Union, 2016), not advice for a person. A clinician or pharmacist decides what is right for an individual. Other products may differ in strength and make-up, as the Cochrane review noted. [1]

Safety

  • Common effects: clinical studies found pygeum generally well tolerated, with mild effects such as diarrhea, nausea, constipation and headache. [4] The EU monograph lists rare digestive upset. [2]
  • Allergy: the EU monograph lists hypersensitivity to the active substance as a contraindication. [2]
  • Medicines: the EU monograph says no interactions have been reported. [2] Drug interactions from clinical trials or case studies were not reported in the EU assessment either. [3] Absence of reports is not proof of safety. Ask a pharmacist (how interactions work).
  • PSA test: whether pygeum affects the PSA blood test is not described in the sources we read. Tell your clinician about any prostate herb before testing.
  • Women, children, pregnancy and breastfeeding: the EU monograph says there is no relevant use in women, adolescents and children under 18, and that pregnancy and lactation are not relevant. [2]
  • Long-term use: the EU monograph says long-term use is possible. [2]
  • Liver, kidney, surgery: not described in the sources we read.
  • Quality: see quality testing and certifications.

Frequently asked questions

Is pygeum meant for women or children?

The EU monograph says there is no relevant use in women, adolescents and children under 18. [2]

Does pygeum work for BPH?

A Cochrane review found improvement in symptoms versus placebo, but trials were small, short and varied. [1]

Should I see a doctor before using it?

Yes. The EU monograph says to use it only after serious conditions have been excluded by a doctor. [2]

Is pygeum endangered?

The tree is listed in CITES Appendix II owing to overexploitation, according to a European assessment report. [3]

What is the scientific name?

Prunus africana (Hook.fil.) Kalkman, family Rosaceae. [5]

References
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.